Posted on 26/04/2011 in Pharmaceutical Company Product News Merck Sharpe and Dohme and its partner Sanofi Pasteur have commenced a clinical study of a new vaccine designed to treat a range of diseases among children. The companies have begun a phase III study of the hexavalent combination vaccine that will test the safety and immunogenicity […]